Determination of the antihypertensive peptide LHLPLP in fermented milk by high-performance liquid chromatography-mass spectrometry

Journal of Dairy Science

Volumn 89, Issue 12, 2006, Pages 4527-4535

  Quiros A ^a   Ramos, M ^a   Muguerza, B ^b   Delgado, M A ^b   Martin Alvarez P J ^a   Aleixandre, A ^c   Recio, I ^a  

^a INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

^b Grupo Leche Pascual   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

Author keywords

Antihypertensive peptide; Enterococcus faecalis; Mass spectrometry; Quantification

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS;

EID: 33846293676     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(06)72501-2     Document Type: Article

References (29)

1. Araujo, P., and L. Froyland. 2006. Optimisation of an extraction method for the determination of prostaglandin E2 in plasma using experimental design and liquid chromatography tandem mass spectrometry. J. Chromatogr. B. 830:212-217.
2. Breci, L. A., D. L. Tabb, J. R. Yates, and V. H. Wysocki. 2003. Cleavage N-terminal to proline: Analysis of a database of peptide tandem mass spectra. Anal. Chem. 75:1963-1971.
3. Curtis, J. M., D. Dennis, D. S. Waddell, T. MacGillivray, and H. S. Ewart. 2002. Determination of angiotensin-converting enzyme inhibitory peptide Leu-Lys-Pro-Asn-Met (LKPNM) in bonito muscle hydrolysates by LC-MS/MS. J. Agric. Food Chem. 50:3919-3925.
4. Fuglsang, A., D. Nilsson, and N. C. B. Nyborg. 2003. Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo. J. Enzym. Inhib. Med. Chem. 18:407-412.
5. Gobbetti, M., P. Ferranti, E. Smacchi, F. Goffredi, and F. Addeo. 2000. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66:3898-3904.
6. Hata, Y., M. Yamamoto, M. Ohni, K. Nakajiima, Y. Nakamura, and T. Takano. 1996. A placebo-controlled study of the effect of sour milk on arterial blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64:767-771.
7. Hernández-Ledesma, B., L. Amigo, M. Ramos, and I. Recio. 2004. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J. Agric. Food Chem. 52:1504-1510.
8. Holstege, D. M., B. Puschner, G. Whitehead, and F. D. Galey. 2002. Screening and mass spectral confirmation of β-lactam antibiotic residues in milk using LC-MS/MS. J. Agric. Food Chem. 50:406-111.
9. Leclerc, P.-L., S. F. Gauthier, H. Bachelard, M. Santure, and D. Roy. 2002. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. Int. Dairy J. 12:995-1004.
10. Li, G. H., G. W. Le, Y. H. Shi, and S. Shrestha. 2004. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr. Res. 24:469-486.
11. Massart, D. L., B. G. M. Vandeginste, S. N. Deming, Y. Michotte, and L. Kaufman. 1990. Chemometrics: A Textbook, Elsevier, Amsterdam.
12. Matsuura, K., S. Mizuno, S. Nishimura, T. Gotou, and N. Yamamoto. 2005. Quantitative analysis of the antihypertensive peptides Val-Pro-Pro and Ile-Pro-Pro in casein hydrolyzate using an Aspergillus oryzae protease: An LC-MS method. Milchwiss. Milk Sci. Int. 60:24-27.
13. Miguel, M., B. Muguerza, E. Sanchez, M. A. Delgado, I. Recio, M. Ramos, and A. Aleixandre. 2005. Changes in arterial blood pressure in hypertensive rats caused by long-term intake of milk fermented by Enterococcus faecalis CECT 5728. Br. J. Nutr. 94:36-43.
14. Miller, J. N., and J. C. Miller. 2000. Statistics and Chemometrics for Analytical Chemistry. Pearson Education, Harlow, UK.
15. Mizuno, S., K. Matsuura, T. Gotou, S. Nishimura, O. Kajimoto, M. Yabune, Y. Kajimoto, and N. Yamamoto. 2005. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br. J. Nutr. 94:84-91.
16. Muguerza, B., M. Ramos, E. Sanchez, M. A. Manso, M. Miguel, A. Aleixander, M. A. Delgado, and I. Recio. 2006. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. Int. Dairy J. 16:61-69.
17. Nakamura, Y., N. Yamamoto, K. Sakai, and T. Takano. 1995. Purification and characterization of angiotensin-I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78:777-783.
18. Papayannopoulos, I. A. 1995. The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spectrom. Rev. 14:49-73.
19. Quirós, A., B. Hernandez-Ledesma, M. Ramos, L. Amigo, and I. Recio. 2005. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J. Dairy Sci. 88:3480-3487.
20. Quirós, A., M. Ramos, B. Muguerza, M. A. Delgado, M. Miguel, A. Aleixandre, and I. Recio. 2006. Identification of novel antihypertensive peptides in milk fermented with Enterococus faecalis. Int. Dairy J. doi:10.1016/j.idairyj.2005.12.011
21. Robert, M. C., A. Razaname, M. Mutter, and M. A. Juillerat. 2004. Peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. J. Agric. Food Chem. 52:6923-6931.
22. Roepstorff, P., and J. Fohlman. 1984. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11:601.
23. Rokka, T., E. L. Syvaoja, J. Tuominen, and H. Korhonen. 1997. Release of bioactive peptides by enzymatic proteolysis of lactobacillus GG fermented UHT milk. Milchwiss. Milk Sci. Int. 52:675-678.
24. Seppo, L. M., T. Jauhiainen, T. Poussa, and R. Korpela. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77:326-330.
25. Silva, S. V., and F. X. Malcata. 2005. Caseins as source of bioactive peptides. Int. Dairy J. 15:1-15.
26. Sipola, M., P. Finckenberg, J. Santisteban, R. Korpela, H. Vapaatalo, and M.-L. Nurminen. 2001. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52:745-754.
27. Vermeirssen, V., J. Van Camp, K. Decroos, L. Van Wijmelbeke, and W. Verstraete. 2003. The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. J. Dairy Sci. 86:429-438.
28. Walsh, D. J., H. Bernard, B. A. Murray, J. MacDonald, A. K. Pentzien, G. A. Wright, J. M. Wal, A. D. Struthers, H. Meisel, and R. J. FitzGerald. 2004. J. Dairy Sci. 87:3845-3857.
29. Yamamoto, N., M. Maeno, and T. Takano. 1999. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82:1388-1393.